“Progression free survival by the treatment with Cabozatinib in a case of BRAF mutated Radioiodine refractory recurrent metastatic Papillary Carcinoma Thyroid” (2026) Bangladesh Journal of Otorhinolaryngology, 31(2), pp. 86–94. doi:10.3329/bjo.v31i2.89000.